
 Scientific claim: Dexamethasone increases risk of postoperative bleeding. 
 Participant Dynamics: Practitioner vs. Decision-Maker 
 Contextual Arena: The Personal Arena (goal: to resolve a personal, high-stakes matter) 
 Interaction Trigger: A Recent Discovery (new, urgent data) 
 Dialogue Objective: To Define the Disagreement (map out points of conflict) 
```
Practitioner: I've just read the latest study, and it seems dexamethasone might increase the risk of postoperative bleeding. 

Decision-Maker: Really? That’s quite a claim. What are the details?

Practitioner: The study was published in a reputable journal. They conducted a meta-analysis of several trials involving thousands of patients. The results showed a statistically significant increase in bleeding incidents.

Decision-Maker: But dexamethasone is a staple in our protocol for reducing inflammation. Are they suggesting we stop using it altogether?

Practitioner: Not exactly. The recommendation is to reassess its use, especially in patients with a known bleeding risk. It’s more about being cautious and tailoring our approach.

Decision-Maker: I understand the caution, but altering our protocol isn't a decision we can take lightly. Was the increase in bleeding severe or manageable?

Practitioner: The study didn't distinguish all the cases as severe, but any increase in bleeding can complicate recovery. The concern is more about the potential for harm outweighing the benefits in certain patients.

Decision-Maker: So, you're saying we need to strike a balance between inflammation control and bleeding risk. 

Practitioner: Precisely. My suggestion is to review our patient profiles and consider alternatives or adjusted dosing where necessary.

Decision-Maker: Alright, but we must also consider the potential repercussions of changing a well-established practice. Have there been any discussions on what alternatives might be viable?

Practitioner: Yes, the study mentions alternatives like NSAIDs, though they come with their own risks. A comprehensive risk assessment for each patient is key.

Decision-Maker: Understood. Let's arrange a meeting with the team to review the data and explore possible adjustments to our protocol. We need a decision that aligns with patient safety and our clinical goals.

Practitioner: Agreed. I’ll prepare a summary of the findings for our discussion.

Decision-Maker: Thank you. Let’s ensure we’re making informed choices for our patients’ best outcomes.
```